STAT3 and diabetes mellitus: Another study on diabetes in mice induced with a high-sucrose and high-fat diet showed that 14-week treatment with anagliptin, an analog of linagliptin, in combination with the hormone leptin, resulted in a reduction in diabetes-associated polyphagia, as well as protection via stimulation of the transcription factor STAT3 [67].